Porsolt will be attending the upcoming Safety Pharmacology Society annual meeting #SPS2023 next week in Brussels (Sep 18 – 21). Please visit our exhibitor booth (#406) to meet our team and learn more about our globally recognized expertise in performing Safety Pharmacology studies, as part of the regulatory process of drug development.
We will also be presenting two important posters:
“Intravenous Self-administration in the rat: Advantages of transcutaneous buttons for improving the Animal Welfare” (Poster SP136), evaluating the advantages of transcutaneous buttons on the wellbeing and behavior of study subjects.
“Dog and Minipig Telemetry Assay Sensitivity to Detect QTc Prolongation: Moxifloxacin Effects by Timepoint and Concentration-QTc Relationship Analysis” (Poster SP066), describing a time-point analysis of the effects of moxifloxacin in dogs and minipigs to determine the sensitivity of the assay. This is in line with the Best Practices guidelines looking at reducing the number of clinical studies.
We look forward to seeing you at SPS and please feel free to contact us (contact@porsolt.com) to schedule a meeting, or to learn more about our Safety Pharmacology expertise.
www.porsolt.com
